BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 10373130)

  • 1. Improved outcome of acute myeloid leukaemia in Down's syndrome.
    Craze JL; Harrison G; Wheatley K; Hann IM; Chessells JM
    Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.
    Creutzig U; Ritter J; Vormoor J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
    Leukemia; 1996 Nov; 10(11):1677-86. PubMed ID: 8892666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G
    Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Down's syndrome with acute leukaemia.
    Levitt GA; Stiller CA; Chessells JM
    Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A; Peeters M; Poon A
    Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
    Kojima S; Sako M; Kato K; Hosoi G; Sato T; Ohara A; Koike K; Okimoto Y; Nishimura S; Akiyama Y; Yoshikawa T; Ishii E; Okamura J; Yazaki M; Hayashi Y; Eguchi M; Tsukimoto I; Ueda K
    Leukemia; 2000 May; 14(5):786-91. PubMed ID: 10803507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy.
    Zubizarreta P; Felice MS; Alfaro E; Fraquelli L; Casak S; Quinteros R; Cygler A; Gallego M; Pérez LE; Sackmann-Muriel F
    Leuk Res; 1998 May; 22(5):465-72. PubMed ID: 9652734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's Syndrome-Transient Abnormal Myelopoiesis and Acute Leukaemia.
    Bain B
    Leuk Lymphoma; 1991; 3(5-6):309-17. PubMed ID: 27467421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoplastic disorders of hematopoiesis in children with Down's syndrome--a single institution experience in Taiwan.
    Chang HH; Lu MY; Jou ST; Lin KH; Tien HF; Wu ET; Lin DT
    J Formos Med Assoc; 2005 May; 104(5):333-40. PubMed ID: 15959600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Down's syndrome and leukemia].
    Bermúdez Cortés M; Verdeguer Miralles A; Jovaní Casano C; Cañete Nieto A; Fernández JM; Ferris Tortajada J; Castel Sánchez V
    An Esp Pediatr; 1998 Jun; 48(6):593-8. PubMed ID: 9662842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM; Mick R; Johnson FL
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
    Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
    Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
    Wheeler K; Chessells JM; Bailey CC; Richards SM
    Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.
    Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G
    Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
    Fong CT; Brodeur GM
    Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transient myeloproliferation and acute myeloid leukemia in infants with Down's syndrome].
    Creutzig U; Ritter J; Vormoor J; Eschenbach C; Dickerhoff R; Burdach S; Scheel-Walter HG; Kühl J; Schellong G
    Klin Padiatr; 1990; 202(4):253-7. PubMed ID: 2144325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.